Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Leblanc

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Veterinary and Comparative Oncology|January 22, 2013
Serial evaluation of neutrophil function in tumour-bearing dogs undergoing chemotherapyA K LeBlanc, C J LeBlanc, B W Rohrbach, et al.
Veterinary and Comparative Oncology|January 13, 2012
Expression of PDGFR-β and Kit in canine anal sac apocrine gland adenocarcinoma using tissue immunohistochemistryR J Brown, S J Newman, D C Durtschi, et al.
Veterinary Pathology|August 10, 2011
C-kit expression in canine mucosal melanomasS J Newman, J M Jankovsky, B W Rohrbach, et al.
Veterinary and Comparative Oncology|January 13, 2012
Radiotherapy-induced myelosuppression in dogs: 103 cases (2002-2006)T Clermont, A K Leblanc, W H Adams, et al.
Veterinary and Comparative Oncology|August 18, 2023
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogsK I Silver, S Patkar, C Mazcko, et al.
Communications Biology|May 15, 2025
The tumor microenvironment of metastatic osteosarcoma in the human and canine lungL E McGee, J S Pereira, T A McEachron, et al.
Veterinary Pathology|May 5, 2006
Carcinoma ex pleomorphic adenoma with sebaceous differentiation in the mandibular salivary gland of a dogO A Smrkovski, A K LeBlanc, S H Smith, et al.
Journal of Veterinary Internal Medicine|August 22, 2007
Effects of L-asparaginase on plasma amino acid profiles and tumor burden in cats with lymphomaA K LeBlanc, S K Cox, C A Kirk, et al.
Veterinary and Comparative Oncology|September 17, 2009
Efficacy and toxicity of BOPP and LOPP chemotherapy for the treatment of relapsed canine lymphomaA K LeBlanc, G E Mauldin, R J Milner, et al.
Cancer & Metabolism|March 12, 2020
Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcomaL Ren, V Ruiz-Rodado, T Dowdy, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Veterinary and Comparative Oncology|January 22, 2013
Serial evaluation of neutrophil function in tumour-bearing dogs undergoing chemotherapyA K LeBlanc, C J LeBlanc, B W Rohrbach, et al.
Veterinary and Comparative Oncology|January 13, 2012
Expression of PDGFR-β and Kit in canine anal sac apocrine gland adenocarcinoma using tissue immunohistochemistryR J Brown, S J Newman, D C Durtschi, et al.
Veterinary Pathology|August 10, 2011
C-kit expression in canine mucosal melanomasS J Newman, J M Jankovsky, B W Rohrbach, et al.
Veterinary and Comparative Oncology|January 13, 2012
Radiotherapy-induced myelosuppression in dogs: 103 cases (2002-2006)T Clermont, A K Leblanc, W H Adams, et al.
Veterinary and Comparative Oncology|August 18, 2023
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogsK I Silver, S Patkar, C Mazcko, et al.
Communications Biology|May 15, 2025
The tumor microenvironment of metastatic osteosarcoma in the human and canine lungL E McGee, J S Pereira, T A McEachron, et al.
Veterinary Pathology|May 5, 2006
Carcinoma ex pleomorphic adenoma with sebaceous differentiation in the mandibular salivary gland of a dogO A Smrkovski, A K LeBlanc, S H Smith, et al.
Journal of Veterinary Internal Medicine|August 22, 2007
Effects of L-asparaginase on plasma amino acid profiles and tumor burden in cats with lymphomaA K LeBlanc, S K Cox, C A Kirk, et al.
Veterinary and Comparative Oncology|September 17, 2009
Efficacy and toxicity of BOPP and LOPP chemotherapy for the treatment of relapsed canine lymphomaA K LeBlanc, G E Mauldin, R J Milner, et al.
Cancer & Metabolism|March 12, 2020
Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcomaL Ren, V Ruiz-Rodado, T Dowdy, et al.
Pageof 1